Russek-Blum Niva bought NRSN
March 26, 2026 · Form 4 insider transaction
Russek-Blum Niva bought 200,000 shares of NeuroSense Therapeutics Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
200,000
Price
$0.00
Total value
N/A
InsiderRussek-Blum Niva
Role—
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateMarch 26, 2026
Filing dateMarch 30, 2026
Shares owned after467,953
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee or director in connection with the Issuer's 2018 Share Incentive Plan must be registered in the name of a trustee.; The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date.